Literature DB >> 7476971

Pituitary-type transcription of the human prolactin gene in the absence of Pit-1.

B Gellersen1, R Kempf, R Telgmann, G E DiMattia.   

Abstract

We describe a human (h) PRL-producing cell line, SKUT-1B-20, which we isolated as a subclone of a uterine sarcoma cell line. Although this cell line is of uterine origin, it does not use the decidual-specific upstream promoter of the hPRL gene, but transcribes the hPRL gene from the downstream pituitary-type transcription start site, as determined by Northern blot, reverse transcriptase-polymerase chain reaction and primer extension analyses. This is particularly intriguing because SKUT-1B-20 cells lack the transcription factor Pit-1. No Pit-1 messenger RNA was detectable by reverse transcriptase-polymerase chain reaction, and endogenous Pit-1 target genes (GH, PRL, and Pit-1) were refractory to transfected Pit-1 expression vector, whereas in cotransfection experiments, Pit-1 efficiently activated reporter gene fusion constructs carrying 5'-flanking sequences of the human and rat PRL or the mouse Pit-1 genes. By transfecting reporter genes containing 8.7 kilobases of DNA flanking the hPRL pituitary-specific start site (hPRL-8700/Luc) and deletions thereof, we located a Pit-1-independent cis-active region more than 7 kilobases upstream of the start site. The most distal 1650 or 880 base pairs of the hPRL genomic fragment (which extends to -8784 base pairs), when placed directly upstream of the homologous hPRL or the heterologous thymidine kinase promoters, conferred transcriptional activation to those promoters. SKUT-1B-20 cell-specific activation of hPRL-8700/Luc could not be suppressed by the introduction of an inhibitor of protein kinase A (PKA), PKI. This is the first demonstration of pituitary-type PRL gene transcription independent of Pit-1 and activation of the PKA pathway. The SKUT-1B-20 cell line was then used in reconstitution experiments to delineate the role of Pit-1 in modulating the transcriptional effects of phorbol ester, PKA, and estrogen receptor (ER) on the hPRL gene. The low response of hPRL/luciferase fusion genes to phorbol ester was greatly enhanced by cotransfected Pit-1 and was mediated by the proximal region between -250 and -38. The catalytic subunit of PKA, C beta, was able to elicit a moderate induction of hPRL-8700/Luc even in the absence of Pit-1. A potential estrogen response element has been located in the hPRL gene sequence at a position similar to that of the estrogen response element of the rat PRL gene immediately adjacent to the distal enhancer.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7476971     DOI: 10.1210/mend.9.7.7476971

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  7 in total

Review 1.  What can we learn from rodents about prolactin in humans?

Authors:  Nira Ben-Jonathan; Christopher R LaPensee; Elizabeth W LaPensee
Journal:  Endocr Rev       Date:  2007-12-05       Impact factor: 19.871

2.  Tumor necrosis factor-alpha activates the human prolactin gene promoter via nuclear factor-kappaB signaling.

Authors:  Sönke Friedrichsen; Claire V Harper; Sabrina Semprini; Michael Wilding; Antony D Adamson; Dave G Spiller; Glyn Nelson; John J Mullins; Michael R H White; Julian R E Davis
Journal:  Endocrinology       Date:  2005-10-27       Impact factor: 4.736

Review 3.  The prolactin gene: a paradigm of tissue-specific gene regulation with complex temporal transcription dynamics.

Authors:  K Featherstone; M R H White; J R E Davis
Journal:  J Neuroendocrinol       Date:  2012-07       Impact factor: 3.627

4.  The Pit-1/Pou1f1 transcription factor regulates and correlates with prolactin expression in human breast cell lines and tumors.

Authors:  I Ben-Batalla; S Seoane; M Macia; T Garcia-Caballero; L O Gonzalez; F Vizoso; R Perez-Fernandez
Journal:  Endocr Relat Cancer       Date:  2010-01-29       Impact factor: 5.678

5.  SOX2 regulates the hypothalamic-pituitary axis at multiple levels.

Authors:  Sujatha A Jayakody; Cynthia L Andoniadou; Carles Gaston-Massuet; Massimo Signore; Anna Cariboni; Pierre M Bouloux; Paul Le Tissier; Larysa H Pevny; Mehul T Dattani; Juan P Martinez-Barbera
Journal:  J Clin Invest       Date:  2012-09-04       Impact factor: 14.808

6.  Human prolactin gene promoter regulation by estrogen: convergence with tumor necrosis factor-alpha signaling.

Authors:  A D Adamson; S Friedrichsen; S Semprini; C V Harper; J J Mullins; M R H White; J R E Davis
Journal:  Endocrinology       Date:  2007-11-15       Impact factor: 4.736

Review 7.  The role of cyclic nucleotides in pituitary lactotroph functions.

Authors:  Marek Kucka; Ivana Bjelobaba; Melanija Tomić; Stanko S Stojilkovic
Journal:  Front Endocrinol (Lausanne)       Date:  2013-09-13       Impact factor: 5.555

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.